Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

Sanarus Medical, Inc. · Predicate Candidate Screening

14 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

52 daysmedian FDA review time
98 days90th percentile
14clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K080171SANARUS INCORE ROTATIONAL CORE BIOPSY DEVICE, MODELS CB3010,Sanarus Medical, Inc.2008-03-06420
K073533SANARUS V2 TREATMENT SYSTEMSanarus Medical, Inc.2008-02-07520
K062896V2 TREATMENT SYSTEM (V2 CONSOLE, V2 ICE PROBE, V2 DEWARS) MOSanarus Medical, Inc.2007-01-03980
K061510SANARUS VISICA TREATMENT SYSTEMSanarus Medical, Inc.2006-07-18470
K052861MODIFICATION TO:SANARUS VISICA TREATMENT SYSTEM , MODELS VS2Sanarus Medical, Inc.2005-11-15350
K051581SANARUS CASSI II ROTATIONAL CORE BIOPSY SYSTEM, MODEL CS2000Sanarus Medical, Inc.2005-07-27420
K042136SANARUS CASSI ROTATIONAL CORE BIOPSY SYSTEMSanarus Medical, Inc.2004-09-08300
K032506SANARUS CENTRICA II ROTATIONAL CORE BIOPSY SYSTEMSanarus Medical, Inc.2003-10-09560
K020054SANARUS INDICA MARKER SYSTEMSanarus Medical, Inc.2002-10-162810
K022314SANARUS VISICA TREATMENT SYSTEMSanarus Medical, Inc.2002-10-15901
K022879MODIFICATION TO SANARUS CENTRICA CORE TISSUE BIOPSYSanarus Medical, Inc.2002-09-23241
K021137SANARUS CENTRICA CORE TISSUE BIOPSY SYSTEMSanarus Medical, Inc.2002-06-26780
K021211MODIFICATION TO SANARUS VISICA TREATMENT SYSTEMSanarus Medical, Inc.2002-06-26700
K020605SANARUS VISICA TREATMENT SYSTEMSanarus Medical, Inc.2002-03-08110

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda